[1]
|
NUCLEOTIDE SEQUENCE [MRNA].
PubMed=8388392 [NCBI, ExPASy, EBI, Israel, Japan]
Zheng C.-F.,
Guan K.-L.;
"Cloning and characterization of two distinct human extracellular signal-regulated kinase activator kinases, MEK1 and MEK2.";
J. Biol. Chem. 268:11435-11439(1993).
|
[2]
|
NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
TISSUE=Muscle, and Skin;
DOI=10.1101/gr.2596504; PubMed=15489334 [NCBI, ExPASy, EBI, Israel, Japan]
The MGC Project Team;
"The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).";
Genome Res. 14:2121-2127(2004).
|
[3]
|
PROTEIN SEQUENCE OF 40-51; 53-61; 64-100; 102-112; 164-172; 194-205; 265-297; 362-371 AND 389-397, PHOSPHORYLATION AT THR-394, AND MASS SPECTROMETRY.
TISSUE=Colon carcinoma;
Bienvenut W.V.,
Zebisch A.,
Kolch W.;
Submitted (DEC-2008) to UniProtKB.
|
[4]
|
CLEAVAGE BY ANTHRAX LETHAL FACTOR.
DOI=10.1126/science.280.5364.734; PubMed=9563949 [NCBI, ExPASy, EBI, Israel, Japan]
Duesbery N.S.,
Webb C.P.,
Leppla S.H.,
Gordon V.M.,
Klimpel K.R.,
Copeland T.D.,
Ahn N.G.,
Oskarsson M.K.,
Fukasawa K.,
Paull K.D.,
Vande Woude G.F.;
"Proteolytic inactivation of MAP-kinase-kinase by anthrax lethal factor.";
Science 280:734-737(1998).
|
[5]
|
CLEAVAGE BY ANTHRAX LETHAL FACTOR.
DOI=10.1042/0264-6021:3520739; PubMed=11104681 [NCBI, ExPASy, EBI, Israel, Japan]
Vitale G.,
Bernardi L.,
Napolitani G.,
Mock M.,
Montecucco C.;
"Susceptibility of mitogen-activated protein kinase kinase family members to proteolysis by anthrax lethal factor.";
Biochem. J. 352:739-745(2000).
|
[6]
|
PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-394, AND MASS SPECTROMETRY.
TISSUE=Epithelium;
DOI=10.1073/pnas.0404720101; PubMed=15302935 [NCBI, ExPASy, EBI, Israel, Japan]
Beausoleil S.A.,
Jedrychowski M.,
Schwartz D.,
Elias J.E.,
Villen J.,
Li J.,
Cohn M.A.,
Cantley L.C.,
Gygi S.P.;
"Large-scale characterization of HeLa cell nuclear phosphoproteins.";
Proc. Natl. Acad. Sci. U.S.A. 101:12130-12135(2004).
|
[7]
|
PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-23 AND THR-394, AND MASS SPECTROMETRY.
TISSUE=Epithelium;
DOI=10.1016/j.cell.2006.09.026; PubMed=17081983 [NCBI, ExPASy, EBI, Israel, Japan]
Olsen J.V.,
Blagoev B.,
Gnad F.,
Macek B.,
Kumar C.,
Mortensen P.,
Mann M.;
"Global, in vivo, and site-specific phosphorylation dynamics in signaling networks.";
Cell 127:635-648(2006).
|
[8]
|
PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-396, AND MASS SPECTROMETRY.
TISSUE=Epithelium;
DOI=10.1038/nbt1240; PubMed=16964243 [NCBI, ExPASy, EBI, Israel, Japan]
Beausoleil S.A.,
Villen J.,
Gerber S.A.,
Rush J.,
Gygi S.P.;
"A probability-based approach for high-throughput protein phosphorylation analysis and site localization.";
Nat. Biotechnol. 24:1285-1292(2006).
|
[9]
|
PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-226 AND THR-394, AND MASS SPECTROMETRY.
DOI=10.1074/mcp.T600062-MCP200; PubMed=17192257 [NCBI, ExPASy, EBI, Israel, Japan]
Wissing J.,
Jaensch L.,
Nimtz M.,
Dieterich G.,
Hornberger R.,
Keri G.,
Wehland J.,
Daub H.;
"Proteomics analysis of protein kinases by target class-selective prefractionation and tandem mass spectrometry.";
Mol. Cell. Proteomics 6:537-547(2007).
|
[10]
|
PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-396, AND MASS SPECTROMETRY.
DOI=10.2116/analsci.24.161; PubMed=18187866 [NCBI, ExPASy, EBI, Israel, Japan]
Imami K.,
Sugiyama N.,
Kyono Y.,
Tomita M.,
Ishihama Y.;
"Automated phosphoproteome analysis for cultured cancer cells by two-dimensional nanoLC-MS using a calcined titania/C18 biphasic column.";
Anal. Sci. 24:161-166(2008).
|
[11]
|
PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-394 AND THR-396, AND MASS SPECTROMETRY.
TISSUE=Platelet;
DOI=10.1021/pr0704130; PubMed=18088087 [NCBI, ExPASy, EBI, Israel, Japan]
Zahedi R.P.,
Lewandrowski U.,
Wiesner J.,
Wortelkamp S.,
Moebius J.,
Schuetz C.,
Walter U.,
Gambaryan S.,
Sickmann A.;
"Phosphoproteome of resting human platelets.";
J. Proteome Res. 7:526-534(2008).
|
[12]
|
PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-23; SER-293; SER-295 AND THR-396, AND MASS SPECTROMETRY.
DOI=10.1016/j.molcel.2008.07.007; PubMed=18691976 [NCBI, ExPASy, EBI, Israel, Japan]
Daub H.,
Olsen J.V.,
Bairlein M.,
Gnad F.,
Oppermann F.S.,
Korner R.,
Greff Z.,
Keri G.,
Stemmann O.,
Mann M.;
"Kinase-selective enrichment enables quantitative phosphoproteomics of the kinome across the cell cycle.";
Mol. Cell 31:438-448(2008).
|
[13]
|
PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-222; SER-226; THR-394 AND THR-396, AND MASS SPECTROMETRY.
DOI=10.1073/pnas.0805139105; PubMed=18669648 [NCBI, ExPASy, EBI, Israel, Japan]
Dephoure N.,
Zhou C.,
Villen J.,
Beausoleil S.A.,
Bakalarski C.E.,
Elledge S.J.,
Gygi S.P.;
"A quantitative atlas of mitotic phosphorylation.";
Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
|
[14]
|
IDENTIFICATION [LARGE SCALE ANALYSIS], AND MASS SPECTROMETRY.
Colinge J.,
Superti-Furga G.,
Bennett K.L.;
Submitted (OCT-2008) to UniProtKB.
|
[15]
|
VARIANT CFC SYNDROME CYS-57.
DOI=10.1126/science.1124642; PubMed=16439621 [NCBI, ExPASy, EBI, Israel, Japan]
Rodriguez-Viciana P.,
Tetsu O.,
Tidyman W.E.,
Estep A.L.,
Conger B.A.,
Cruz M.S.,
McCormick F.,
Rauen K.A.;
"Germline mutations in genes within the MAPK pathway cause cardio-facio-cutaneous syndrome.";
Science 311:1287-1290(2006).
|
|
ExPASy Home page
SIB Switzerland
